Form 4 holding
Director
Akebia Therapeutics, Inc.
- Security class
- Stock Option (Right to buy)
- Shares / value
- 214,400
- Estimated value
- Report date
- 01 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount